Principal Scientist to Associate Director, Chemistry

Shanghai · On-site

About this role

About Us:

Structure Therapeutics develops life‐changing medicines for patients using advanced structure‐based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.

Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.

Position Summary:

Reporting to the Senior Director of Chemistry, this position will be responsible for leading SAR studies of one or more GKAR chemical series to deliver milestones working closely with biology/Sbio/CADD/IP/CRO.



Job Responsibilities:

  • As a dynamic chemistry leader, drive and direct medicinal chemistry functions for one or more drug discovery projects, working in concert with cross functional team members.
  • Analyze screening data, perform literature reviews, design, propose, and execute medicinal chemistry plans, coordinate chemistry and biology data to support compound progression and patent strategies.
  • Supervise and direct synthetic chemistry activities at contract research organizations (CROs).
  • Serve as a scientific expert in medicinal chemistry with both internal and external partners and provide recommendations regarding new targets and emerging external opportunities.

Qualifications:

  • PhD in Organic or Medicinal Chemistry or its equivalent and 5-10 years industry experience in small molecule medicinal chemistry
  • Demonstrated advancement of projects through various stages of drug discovery and delivery of clinical candidates
  • Proficiency in complex problem-solving and expert knowledge of modern methods of synthetic/medicinal chemistry
  • Familiarity with structure-based drug discovery, experience of working closely with computational chemists as part of project team
  • Track record of scientific contributions including peer reviewed publications, patent applications
  • Highly motivated, open-minded, results driven individual with excellent organizational, interpersonal and communication skills

Company at a glance

Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.

Founded2017
Team Size51-200 employees
WorkspaceOn-site
IndustryBiotechnology Research
Location
Pudong, Shanghai, China

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

Know someone who'd be great for this?